Design and rationale of the PROTECT study: a placebo-controlled randomized study of the selective A1 adenosine receptor antagonist rolofylline for patients hospitalized with acute decompensated heart failure and volume overload to assess treatment e (Q43177885)

From Wikidata
Jump to navigation Jump to search
scientific article published on 11 December 2009
edit
Language Label Description Also known as
English
Design and rationale of the PROTECT study: a placebo-controlled randomized study of the selective A1 adenosine receptor antagonist rolofylline for patients hospitalized with acute decompensated heart failure and volume overload to assess treatment e
scientific article published on 11 December 2009

    Statements

    Design and rationale of the PROTECT study: a placebo-controlled randomized study of the selective A1 adenosine receptor antagonist rolofylline for patients hospitalized with acute decompensated heart failure and volume overload to assess treatment e (English)
    Paul DeLucca
    PROTECT Steering Committee, Investigators, and Coordinators
    11 December 2009
    25-35

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit